ONTAK Trademark

Trademark Overview

On Friday, May 17, 2019, a trademark application was filed for ONTAK with the United States Patent and Trademark Office. The USPTO has given the ONTAK trademark a serial number of 88435818. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 24, 2022. This trademark is owned by Eisai Inc.. The ONTAK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
ontak

General Information

Serial Number88435818
Word MarkONTAK
Filing DateFriday, May 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEisai Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNutley, NJ 07110
Party NameEisai Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677

Trademark Events

Event DateEvent Description
Monday, October 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, February 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022SOU EXTENSION 5 GRANTED
Monday, February 14, 2022SOU EXTENSION 5 FILED
Tuesday, February 22, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 14, 2022TEAS EXTENSION RECEIVED
Thursday, September 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 7, 2021SOU EXTENSION 4 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 4 FILED
Tuesday, September 7, 2021TEAS EXTENSION RECEIVED
Tuesday, March 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 12, 2021SOU EXTENSION 3 GRANTED
Friday, March 12, 2021SOU EXTENSION 3 FILED
Friday, March 12, 2021TEAS EXTENSION RECEIVED
Friday, September 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 9, 2020SOU EXTENSION 2 GRANTED
Wednesday, September 9, 2020SOU EXTENSION 2 FILED
Wednesday, September 9, 2020TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 10, 2020SOU EXTENSION 1 GRANTED
Friday, January 10, 2020SOU EXTENSION 1 FILED
Friday, January 10, 2020TEAS EXTENSION RECEIVED
Tuesday, September 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 8, 2019ASSIGNED TO EXAMINER
Tuesday, June 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 21, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

ontak cancer treatment preparations pharmaceutical